Hanus J, Zhao F, Wang S. Current therapeutic developments in atrophic age-related macular degeneration. Br J Ophthalmol 2016;100:122–7. In the first paragraph of the “Lipofuscin and visual cycle inhibitors” section of the paper (p. 124), the authors state “A2E, derived from vitamin E, is a byproduct of the visual cycle and a component of lipofuscin”. This sentence should read: “A2E, derived from vitamin A, is a byproduct of the visual cycle and a component of lipofuscin”.